Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2016  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3958    
    Printed117    
    Emailed3    
    PDF Downloaded149    
    Comments [Add]    
    Cited by others 7    

Recommend this journal

 

 
Year : 2001  |  Volume : 49  |  Issue : 1  |  Page : 95--7

Albendazole therapy for solitary persistent cysticercus granuloma.


Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160012, India., India

Correspondence Address:
A Thussu
Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160012, India.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 11303254

Rights and PermissionsRights and Permissions

Use of Albendazole therapy for the treatment of patients having persisting intracranial solitary cysticercus granuloma is controversial. Most of the times these patients are treated empirically with variety of drugs for variable period. Some authors advocate biopsy before definitive treatment. 25 patients having radiologicaly persistent solitary cysticercus granuloma (>6 months) were given 15 days course of oral albendazole (15 mg/kg body wt). Cranial CT scan was repeated one month after the completion of albendazole therapy. It was evaluated for complete resolution, partial response (> 50% decrease in size of lesion) or no change as compared to previous scan. 12 patients (48%) showed complete resolution, 4 patients (16%) showed a partial response, while 9 patients (36%) did not show any change on follow up. Albendazole therapy may be useful for patients having persistent cysticercus granuloma.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow